SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹3,031 Cr | ₹2,254 Cr | ₹2,110 Cr | ₹1,967 Cr | ₹1,576 Cr |
What is the latest Total Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹3,031 Cr |
Mar2024 | ₹2,254 Cr |
Mar2023 | ₹2,110 Cr |
Mar2022 | ₹1,967 Cr |
Mar2021 | ₹1,576 Cr |
How is Total Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,031 Cr | 34.47 | |
Mar2024 | ₹2,254 Cr | 6.83 | |
Mar2023 | ₹2,110 Cr | 7.28 | |
Mar2022 | ₹1,967 Cr | 24.78 | |
Mar2021 | ₹1,576 Cr | - |
Compare Total Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹38,072.5 Cr | 7.8% | 5.7% | -17.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,197.0 Cr | 0.9% | -0.2% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,634.0 Cr | 0.1% | 0.4% | 16.6% | Stock Analytics | |
CIPLA | ₹126,082.0 Cr | 0.5% | 3.8% | -3.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,167.0 Cr | NA | -0.9% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,783.0 Cr | 2.8% | 6.9% | -2% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 7.8% |
5.7% |
-17.8% |
SENSEX | 1% |
2.1% |
0.5% |
You may also like the below Video Courses